Eos Focused Equity Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Eos Focused Equity Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-28,211	Closed	-$1.52M	–	28
2017 Q4	$1.52M	Sell	28,211 -2,028	-7%	-$111K	2.47%	20
2017 Q3	$1.73M	Buy	30,239 +2,776	+10%	+$163K	2.57%	23
2017 Q2	$1.65M	Sell	27,463 -7,779	-22%	-$443K	1.87%	21
2017 Q1	$1.92M	Buy	+35,242	New	+$1.74M	2.03%	22

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Eos Focused Equity Management's BIVV Position: Q1 2018 in Review

Eos Focused Equity Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 28,211 shares — an estimated $1.52M sold.

Eos Focused Equity Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.92M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Eos Focused Equity Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Eos Focused Equity Management sold 28,211 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.52M.
Eos Focused Equity Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Eos Focused Equity Management's Bioverativ Inc. Common Stock position peaked at $1.92M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Eos Focused Equity Management's 13F filing for Q1 2018, filed 9 May 2018.